These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 575503)

  • 21. The purification and partial characterization of human somatomedin C.
    Liberti JP; Miller MS
    J Biol Chem; 1980 Feb; 255(3):1023-9. PubMed ID: 7356647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of [125I]somatomedin A and [125I]somatomedin C radioreceptor assays for somatomedin peptide content in whole and acid-chromatographed plasma.
    Horner JM; Liu F; Hintz RL
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1287-95. PubMed ID: 263658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An improved method for the purification of human insulin-like growth factors I and II.
    Petrides PE; Hintz RL; Bohlen P; Shively JE
    Endocrinology; 1986 May; 118(5):2034-8. PubMed ID: 3698905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial purification, characterization, and assay of a slightly acidic insulin-like peptide (ILAs) from human plasma.
    Posner BI; Guyda HJ; Corvol MT; Rappaport R; Harley C; Goldstein S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1240-50. PubMed ID: 400741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Release of somatomedin-like activity by cultured WI-38 human fibroblasts.
    Atkison PR; Weidman ER; Bhaumick B; Bala RM
    Endocrinology; 1980 Jun; 106(6):2006-12. PubMed ID: 6154572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity.
    Herington AC; Kuffer AD
    Biochem J; 1984 Oct; 223(1):89-96. PubMed ID: 6388566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatomedin-C/insulin-like growth factor 1-like material secreted by porcine Sertoli cells in vitro: characterization and regulation.
    Chatelain PG; Naville D; Saez JM
    Biochem Biophys Res Commun; 1987 Aug; 146(3):1009-17. PubMed ID: 3619911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunoassay of somatomedin B. Application to clinical and physiologic studies.
    Yalow RS; Hall K; Luft R
    J Clin Invest; 1975 Jan; 55(1):127-37. PubMed ID: 803217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The purification and partial characterization of an insulin-like protein from human serum.
    Poffenbarger PL
    J Clin Invest; 1975 Dec; 56(6):1455-63. PubMed ID: 1202080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fetal rat myoblasts release both rat somatomedin-C (SM-C)/insulin-like growth factor I (IGF I) and multiplication-stimulating activity in vitro: partial characterization and biological activity of myoblast-derived SM-C/IGF I.
    Hill DJ; Crace CJ; Nissley SP; Morrell D; Holder AT; Milner RD
    Endocrinology; 1985 Nov; 117(5):2061-72. PubMed ID: 4042975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and characterization of three molecular forms of insulin-like growth factor II from human Cohn paste IV.
    Straczek J; Heulin MH; Chenut AM; Lasbennes A; Geschier C; Belleville F; Nabet P
    J Chromatogr; 1990 Nov; 532(2):237-48. PubMed ID: 2084122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basic peptide with insulin-like activity in human serum.
    Sasaki N; Okabe T; Imai Y; Matsuzaki F; Kosaka K; Wakai K; Tsushima T
    Endocrinol Jpn; 1981 Apr; 28(2):157-67. PubMed ID: 7030722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The polymorphic pattern of somatomedins during human development.
    Blum WF; Ranke MB; Lechner B; Bierich JR
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):445-51. PubMed ID: 3425159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A method for the purification of bovine somatomedin C.
    Glick BR; Michalak M
    Prep Biochem; 1987; 17(1):9-24. PubMed ID: 3588554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of somatomedin-C with an antibody directed against the synthetic C-peptide region of insulin-like growth factor-I.
    Hintz RL; Liu F; Marshall LB; Chang D
    J Clin Endocrinol Metab; 1980 Feb; 50(2):405-7. PubMed ID: 6153391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and partial characterization of IGF-like peptides from Cohn fraction IV of human plasma.
    Van den Brande JL; Hoogerbrugge CM; Beyreuther K; Roepstorff P; Jansen J; van Buul-Offers SC
    Acta Endocrinol (Copenh); 1990 Jun; 122(6):683-95. PubMed ID: 2375232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of insulin-like growth Factors I and II from human plasma.
    Cornell HJ; Boughdady NM; Herington AC
    Prep Biochem; 1984; 14(2):123-38. PubMed ID: 6384997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of human semen insulin-like growth factor-I/somatomedin-C immunoreactivity and binding protein.
    Baxter RC; Martin JL; Handelsman DJ
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):420-7. PubMed ID: 6377788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of a somatomedin from plasma of rats bearing growth hormone secreting tumors.
    Chochinov RH; Mariz IK; Daughaday WH
    Endocrinology; 1977 Feb; 100(2):549-56. PubMed ID: 188631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial characterization of a mitogenic factor with somatomedin-like activity produced by culture WI-38 human fibroblasts.
    Atkison PR; Bala RM
    J Cell Physiol; 1981 Jun; 107(3):317-27. PubMed ID: 6972946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.